 |
|
|
|
|
|
|
The Princess Margaret, with its world-leading research facility, the Ontario Cancer Institute (OCI), is especially well-suited to excel and succeed in developing new drugs for cancer patients. That is because the facility is:
- focused 100 percent on cancer research and treatment, including all types of cancer
|
|
|
- a world leader in basic science research, and
- located in a large, multicultural city which provides a large patient base for clinical studies
This article provides background information on the steps involved in developing a new cancer drug and bringing it to market, followed by descriptions of specific drug development initiatives going on at The Princess Margaret.
»More
Videos:
Dr. Lillian Siu, Co-Director of the Robert and Maggie Bras Drug Development Program, speaks about some of the successes and her aspirations.
Dr. Aaron Schimmer, a Scientist with OCI’s Division of Cancer Genomics and Proteomics and one of the Report on Business Top 40 Under 40 talks about some promising drug developments at The Princess Margaret
|
|
|
|
|
|
|
|
|
|